Delays in mVaccination  “go live"

mVacciNation is a product operating in a complex adaptive industry within an ecosystem of Country, Continental and Global partners. The technology deployment is relatively quick and within the control of Mezzanine. However, the operation of the solution requires the provision of ICT and Implementation services. Further, the dependencies relating to Country level decision-making, vaccine availability, vaccine throughput and clinical support etc. are not within Mezzanine control.

Weak Implementation

Countries must make an upfront commitment, including with full resource support to partner with a reputable, strong Implementation Partner. Ideally, the Implementation Partner should also establish a Country Level support mechanism that includes clinical support and is aligned to AU policies & procedures.

Delayed Decision-making

Country Government’s in alignment with the AU CDC commit to establishing a fully mandated, independent or autonomous mechanism that consists of recognised domain experts to execute on rapid decision-making, akin to Churchill’s “war cabinet”.

No Clinical oversight

Countries will be rolling out potentially many vaccines that may not yet have full regulatory authorisation; in addition, Vaccine Adverse Events are expected. A Clinical Advisory Board is required to support Country decision-making; this can be at a country or continental level.

System failure

mVacciNation is reliant on a functional Internet and GSM connectivity to redeem vaccine tickets (vouchers). If for whatever reason the digital technology goes offline, beneficiaries cannot redeem tokens against vaccination.